Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2010
06/17/2010WO2010031096A8 Antimicrobially and antivirally acting composition
06/17/2010WO2010030735A3 Stabilized coating for pharmaceutical formulations
06/17/2010WO2010030342A3 Heparosan polymers and methods of making and using same for the enhancement of therapeutics
06/17/2010WO2010024615A3 Method for manufacturing sustained release microsphere by solvent flow evaporation method
06/17/2010WO2010024576A3 Sustained release tablet containing talniflumate with enhanced body absorption
06/17/2010WO2010020935A3 Use of monoolein as a new auxiliary lipid in lipofection
06/17/2010WO2010017821A8 Coated tablets with a remaining degradation surface over the time
06/17/2010WO2010004490A3 Electronic pill comprising a medicine reservoir
06/17/2010WO2009158480A3 Stimulation of cartilage formation using reduced pressure treatment and chondrocytes
06/17/2010WO2009113703A3 Orally-disintegrating solid preparation
06/17/2010US20100152683 Topical Dermal Delivery Device For Nitric Oxide Delivery
06/17/2010US20100152649 Apparatus and method for transdermal delivery of parathyroid hormone agents
06/17/2010US20100152410 High molecular weight polymers, devices and method for making and using same
06/17/2010US20100152262 Buccal, polar and non-polar spray containing ondansetron
06/17/2010US20100152149 Formulation
06/17/2010US20100152130 Treatment of cancer with glutamine
06/17/2010US20100152116 Treatment of amyotrophic lateral sclerosis
06/17/2010US20100152111 Polymer-based sustained release device
06/17/2010US20100152097 Polymer-based sustained release device
06/17/2010US20100152095 Wound healing
06/17/2010US20100151038 Granular material for dosage forms
06/17/2010US20100151037 Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound
06/17/2010US20100151036 Multiphase drug delivery system
06/17/2010US20100151035 Pharmaceutical compositions of poorly soluble drugs
06/17/2010US20100151034 Granular pharmaceutical composition of atorvastatin for oral administration
06/17/2010US20100151033 Octreotide depot formulation with constantly high exposure levels
06/17/2010US20100151032 Silver and Zinc Containing Body Care Agent
06/17/2010US20100151031 Discrete size and shape specific organic nanoparticles designed to elicit an immune response
06/17/2010US20100151030 Use of MgO Doped with a Divalent or Trivalent Metal Cation for Removing Arsenic from Water
06/17/2010US20100151029 Anti-infectious hydrogel compositions
06/17/2010US20100151028 Crush resistant delayed-release dosage forms
06/17/2010US20100151027 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
06/17/2010US20100151026 Novel strain of lactobacillus crispatus
06/17/2010US20100151025 Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw
06/17/2010US20100151024 Therapeutic agent for ulcerative colitis
06/17/2010US20100151023 Time delayed release mechanism for energizing composition and method of use
06/17/2010US20100151022 Controlled-release compositions
06/17/2010US20100151021 Compositions Comprising Melperone
06/17/2010US20100151020 Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
06/17/2010US20100151019 SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS WITH POOR AQUEOUS SOLUBILITY AT LOW pH AND METHODS OF USE THEREOF
06/17/2010US20100151018 Sustained-release levetiracetam composition and preparation process
06/17/2010US20100151017 Oral Preparation With Controlled Release
06/17/2010US20100151016 Method for producing pharmaceutical tablet
06/17/2010US20100151015 Compositions Comprising Melperone and Controlled-Release Dosage Forms
06/17/2010US20100151014 Pharmaceutical composition
06/17/2010US20100151013 Gastric acid secretion inhibiting composition
06/17/2010US20100151012 Stabilised pharmaceutical composition containing pregabaline
06/17/2010US20100151011 Solid orally administerable pharmaceutical dosage forms with rapid active principle release
06/17/2010US20100151010 Medicament in a multilayer form
06/17/2010US20100151009 Formulations for delivering insulin
06/17/2010US20100151008 Preparations and Methods for Textile and or Fiber Surface Finishing, Surface Finished Articles Prepared Thereby, and Uses Therefor
06/17/2010US20100151007 Compositions and methods for selective inhibition of vegf
06/17/2010US20100151006 Cancer therapy sensitizer
06/17/2010US20100151005 Targeted carriers for intracellular drug delivery
06/17/2010US20100151004 Modulation of drug sensitivity
06/17/2010US20100151003 Egfr binding peptides and uses thereof
06/17/2010US20100151002 Guggulphospholipid Methods and Compositions
06/17/2010US20100151001 Ethynylated heterodinucleoside phosphate analogs, method for the production thereof, and use thereof
06/17/2010US20100151000 Compositions and methods for modulating immune responses
06/17/2010US20100150999 Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
06/17/2010US20100150998 Vaccines for malaria
06/17/2010US20100150997 Treatment of arthritis
06/17/2010US20100150996 Athletic patch
06/17/2010US20100150995 Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone
06/17/2010US20100150994 Amphiphilic entity nanoparticles
06/17/2010US20100150993 Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement
06/17/2010US20100150992 Methods for Treatment of Ophthalmic Disease of an External Ophthalmic Tissue
06/17/2010US20100150991 Combination Wound Therapy
06/17/2010US20100150990 Treatment of inflammation and/or endotoxic shock
06/17/2010US20100150989 Substrates providing multiple releases of active agents
06/17/2010US20100150988 Film-like orally administered medication and manufacturing method therefor
06/17/2010US20100150987 Method for Manufacturing Edible Film
06/17/2010US20100150986 Film preparation with rapidly dissolving property and flexibility
06/17/2010US20100150983 Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest
06/17/2010US20100150981 Sustained release systems of ascorbic acid phosphate
06/17/2010US20100150977 Camomile treated glove
06/17/2010US20100150976 Biologically degradable multilayer system
06/17/2010US20100150975 Structured Composition Comprising an Encapsulated Active
06/17/2010US20100150970 Administration of Enoxoparin Sodium to Patients 75 Years and Older With ST-Segment Elevation Myocardian Infarction
06/17/2010US20100150933 Cytokine antagonists for neurological and neuropsychiatric disorders
06/17/2010US20100150900 Dry Powder Fibrin Sealant
06/17/2010US20100150844 Use of 8-quinolinol and its analogs to target cancer stem cells
06/17/2010US20100150832 Biodegradable polyketal polymers and methods for their formation and use
06/17/2010US20100150828 Radioactive gold nanoparticles and methods of making and using them
06/17/2010US20100150806 Calcium phosphate granules of the hydroxyapatite type, their preparation process and their applications
06/17/2010CA2780180A1 Composition and method for topical application
06/17/2010CA2746491A1 Contact lens drug delivery device
06/17/2010CA2746457A1 Use of racemates of pinocembrin in preparing medicaments for treating stroke
06/17/2010CA2746442A1 Methods for enhancing stability of polyorthoesters and their formulations
06/17/2010CA2746276A1 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy
06/17/2010CA2746167A1 Process of cracking biofeeds using high zeolite to matrix surface area catalysts
06/17/2010CA2746124A1 Methods and systems for inducing immunologic tolerance to non-self antigens
06/17/2010CA2745980A1 Rifaximin complexes
06/17/2010CA2745934A1 Sustained release systems of ascorbic acid phosphate
06/17/2010CA2745330A1 Compound, medicament, vaccine composition and nanocapsules
06/17/2010CA2745084A1 Ulipristal acetate tablets
06/17/2010CA2744940A1 Methods and compositions for delivery of medicaments to the lungs
06/17/2010CA2743768A1 Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease
06/17/2010CA2742373A1 Stabilized nicotine chewing gum
06/17/2010CA2734283A1 Inhalant formulations comprising a bisphosphonate and a pyrazolone derivative and methods for using the same
1 ... 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 ... 2991